A PHASE 2, MULTI-CENTRE, OPEN-LABEL STUDY OF AVELUMAB (MSB0010718C) IN LOCALLY ADVANCED OR METASTATIC PENILE CANCER PATIENTS UNFIT FOR PLATINUM-BASED CHEMOTHERAPY OR PROGRESSED ON OR AFTER PLATINUM-BASED CHEMOTHERAPY

Registry ID

ALPACA

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

PRINCESS MARGARET CANCER CENTRE

Start date

2019-09-16

Last update

2018-01-09

Conditions

• PENILE CANCER

Related clinical trials

• INTERNATIONAL PENILE ADVANCED CANCER TRIAL - INPACT

View on source registry